What Is Pdt In Dermatology Procedure Uses Results?

Photodynamic therapy, or PDT, is a medical treatment that combines a light-sensitive drug with a specific wavelength of light to destroy abnormal cells. In dermatology, doctors use it mainly to treat certain types of skin damage, precancerous spots, and some skin cancers. The procedure is targeted, meaning it treats the skin lesion while leaving the surrounding healthy skin mostly untouched. It is a well-established treatment, not an experimental one, and it has been used in dermatology for decades.

How Does Photodynamic Therapy Work in Dermatology?

PDT relies on a two-step process. First, a photosensitizing agent is applied to the skin. In dermatology, the most common agent is a topical cream called 5-aminolevulinic acid (ALA) or its methyl ester, MAL. This cream is left on the skin for a specific period, usually 30 minutes to a few hours, depending on the condition being treated.

During this incubation time, the cream is absorbed by the skin cells. Abnormal and rapidly dividing cells take up more of the agent than normal cells do. The agent then converts into a light-sensitive compound inside those cells. The second step involves shining a specific wavelength of light onto the treated area. This light activates the compound, which produces a form of oxygen that damages the targeted cells. The body then clears away these damaged cells over the following days.

The selectivity of this process is what makes PDT valuable. Because normal skin cells absorb less of the photosensitizing agent, they experience less damage. This results in better cosmetic outcomes compared to some other destructive treatments.

What Skin Conditions Is PDT Used To Treat?

PDT is most commonly used for actinic keratoses, which are rough, scaly patches caused by years of sun exposure. These patches are considered precancerous because a small percentage can progress to squamous cell carcinoma if left untreated. PDT is highly effective at clearing these lesions, often with excellent cosmetic results.

Dermatologists also use PDT to treat superficial basal cell carcinoma and squamous cell carcinoma in situ, sometimes called Bowen’s disease. These are early-stage skin cancers that have not spread deeply. PDT is not typically used for invasive or nodular skin cancers because the light does not penetrate deeply enough to treat them effectively.

Beyond cancer treatment, PDT is used for several cosmetic and inflammatory skin conditions. It is FDA-approved for treating actinic keratoses, and it is commonly used off-label for acne, particularly inflammatory acne. Some dermatologists also use it for photodamaged skin, fine lines, and certain types of sun damage. The evidence for its cosmetic benefits is growing, but the strongest evidence remains for actinic keratoses and superficial skin cancers.

What Happens During a PDT Procedure?

The procedure begins with a consultation where the dermatologist examines the skin and determines if PDT is appropriate. If it is, the treatment area is cleaned and prepared. The photosensitizing cream is then applied evenly to the lesion and a margin of surrounding skin. The area is often covered with an occlusive dressing to enhance absorption.

After the incubation period, the cream is wiped off and the area is exposed to the light source. The light exposure itself is usually brief, lasting between 8 and 16 minutes depending on the light source and the condition being treated. Patients typically feel a burning or stinging sensation during the light exposure. This discomfort can range from mild to moderate, and it usually resolves shortly after the light is turned off.

After the procedure, the treated area may be red, swollen, and crusted for several days. This is a normal part of the healing process. Most patients require one to two treatments, though some conditions may need more. The dermatologist will schedule a follow-up visit to assess the response and determine if further treatment is needed.

What Results Can Patients Expect From PDT?

Results depend on the condition being treated. For actinic keratoses, studies consistently show that PDT clears the majority of lesions after one or two sessions. The skin often looks smoother and more even-toned after healing. For superficial basal cell carcinoma, cure rates are comparable to other standard treatments, though PDT may require more than one session.

For acne, the results are more variable. Some patients see significant improvement in inflammatory lesions after one or two treatments, while others see only modest benefit. The improvement is often temporary, and maintenance treatments may be needed to sustain results. The evidence supports PDT as a useful option for acne, but it is not a one-time cure.

Cosmetic improvements in skin texture and tone are often reported by patients who undergo PDT for sun damage. However, these benefits are less rigorously studied than the cancer treatment outcomes. Patients should have realistic expectations and understand that PDT is primarily a medical treatment, not a cosmetic procedure with guaranteed aesthetic outcomes.

What Are the Side Effects and Risks of PDT?

PDT is generally well-tolerated, but it does have side effects. The most common are pain and burning during light exposure. This discomfort is temporary and stops when the light is removed. Some patients describe the sensation as intense, and cooling devices or pain medication may be used to manage it.

After the procedure, the treated skin will look sunburned. Redness, swelling, and crusting are expected and typically last 3 to 7 days. In some cases, blistering or peeling can occur. These effects are temporary and resolve as the skin heals.

Photosensitivity is a significant consideration. The photosensitizing agent can remain in the skin for up to 48 hours after application. During this time, exposure to sunlight or bright indoor light can cause a severe skin reaction. Patients must strictly avoid sun exposure and wear protective clothing and sunscreen for at least 48 hours after the procedure. This is not optional advice; it is a necessary safety measure.

Scarring is uncommon with PDT, which is one of its advantages over surgical treatments. However, pigment changes can occur. The treated area may become lighter or darker than the surrounding skin, and these changes can sometimes last for months. Patients with darker skin tones may be at higher risk for pigment changes, and they should discuss this with their dermatologist before proceeding.

How Does PDT Compare to Other Dermatology Treatments?

PDT is one of several options for treating actinic keratoses and superficial skin cancers. Other options include cryotherapy, which freezes the lesions, and topical chemotherapy creams such as fluorouracil. Each treatment has its own profile of effectiveness, side effects, and cosmetic outcomes.

Cryotherapy is fast and effective for individual lesions, but it does not treat large areas of sun damage. Topical chemotherapy treats the entire field of sun-damaged skin but requires weeks of daily application and causes significant redness and crusting. PDT offers a middle ground: it treats a defined area with a single or short series of procedures, and the healing time is relatively short compared to topical chemotherapy.

For superficial skin cancers, surgical excision is the standard treatment because it allows the tissue to be examined under a microscope to confirm complete removal. PDT does not provide a tissue sample. This is an important limitation. PDT is appropriate only when the dermatologist is confident the lesion is superficial and has not invaded deeper layers.

Who Is a Good Candidate for PDT?

Good candidates for PDT are people with multiple actinic keratoses, especially those covering large areas of sun-damaged skin on the face, scalp, or arms. People with superficial basal cell carcinoma or Bowen’s disease on cosmetically sensitive areas may also be good candidates, particularly if they want to avoid surgery.

People with a history of light-sensitive conditions, such as lupus or porphyria, should not undergo PDT. Pregnant or breastfeeding women should also avoid PDT because the safety of the photosensitizing agents has not been established in these populations. No clinical guidelines currently exist for the use of PDT in pregnant or breastfeeding women, so it is avoided as a precaution.

The decision to use PDT is always individualized. The dermatologist considers the type, number, and location of the lesions, the patient’s skin type, and their preferences for treatment and recovery. Patients should have a thorough discussion with their dermatologist about the expected benefits, the number of sessions required, and the recovery process before committing to the treatment.

What Is Pdt In Dermatology Procedure Uses Results?

Photodynamic therapy is a targeted treatment that uses a photosensitizing agent and light to destroy abnormal skin cells while sparing healthy tissue. Its primary uses are treating actinic keratoses, superficial basal cell carcinoma, and Bowen’s disease. It is also used off-label for acne and cosmetic skin rejuvenation. Results are generally excellent for precancerous lesions, with cure rates comparable to other standard treatments and superior cosmetic outcomes. The procedure involves an incubation period, a brief light exposure, and a recovery period of several days. Side effects are temporary and manageable, and the main risk is photosensitivity in the 48 hours after treatment.